Sign in
Not yet recruitingNo phase

Efficacy of Multi-Type Photolithography Flat Microstructure Lenses for Childhood Myopia Control

Key facts

Who runs it
Shanghai Eye Disease Prevention and Treatment Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
255 people, planned
Started
15 Apr 2026
Expected to end
31 Dec 2027
Type of study
Interventional, 5 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • wearing photolithography plano microstructure lenses with multi-point defocus design, non-fading optical property
  • wearing Plano microstructure lenses featuring multi-point defocus design with aspherical lenslets (Essilor Stellest)
  • wearing Photolithography Plano Microstructure Lenses incorporates a multi-point defocus optical architecture , featuring photochromic properties with a light transmittance of 55% post-activation
  • wearing Photolithography Plano Microstructure Lenses incorporates a multi-point defocus optical architecture , featuring photochromic properties with a light transmittance of 35% post-activation
  • wearing Photolithography Plano Microstructure Lenses designed to reduce contrast sensitivity and featuring a non-fading optical property
Record updated
17 April 2026

Who can take part

Age
6 years to 8 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (20)Hide the full registry criteria

Who can take part

  • Age: 6 years ≤ age ≤ 8 years (calculated based on the informed consent date)
  • The spherical equivalent (SE) of both eyes is 0D to +1.00D (inclusive of boundary values) after cycloplegia
  • Astigmatism: Cylindrical power of both eyes ≤ 1.00D
  • Anisometropia: Difference in spherical equivalent between both eyes ≤ 1.00D
  • Corrected visual acuity: Best corrected visual acuity (BCVA) of both eyes ≥ 1.0 (decimal notation, 5m)
  • General health status: No systemic syndromes that affect ocular development; no long-term use of growth hormone, corticosteroids, or antiepileptic drugs
  • Previous intervention: No use of any myopia control methods within the past 3 months, including but not limited to: multifocal glasses, atropine eye drops, red light therapy, acupuncture, etc
  • Compliance with spectacle wear: Parents ensure that the child wears glasses for ≥8 hours per day
  • Follow-up capability: Ability to attend scheduled follow-ups for 12 months (4 visits in total)
  • Informed consent from guardian: Legal guardian signs the informed consent form; children also sign the assent form

Who cannot take part

  • Used any myopia intervention drugs or devices in the past 3 months
  • History or presence of glaucoma, corneal disease, or other ocular organic disease, or acute or chronic ocular inflammation
  • Combined with systemic major diseases, mental diseases, or systemic collagen metabolism diseases
  • Diagnosis of amblyopia, constant strabismus, and other congenital eye diseases
  • Those who are allergic to the lens material or products related to the study
  • Allergy to mydriatic agents and related ophthalmic medications
  • Allergic to photochromic materials or related dyes; taking photosensitizing drugs; suffering from photo-induced skin or neurological disorders
  • Those who have participated in other similar clinical studies in the past 3 months
  • Unable to understand the study content or unable to cooperate with the follow-up
  • Other reasons why the research doctor believes the patient is not suitable for the study

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Myopia

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if photolithographic flat microstructure lenses work to prevent myopia in children. It will also learn about the safety of different designs of photolithographic flat microstructure lenses. The main questions it aims to answer are:

Read full original descriptionShow less

Are photolithography flat microstructure lenses effective and safe in preventing myopia in children? Does the depth of tinted lenses affect visual quality? Researchers will compare photolithography flat microstructure lenses to a spectacle lenses with aspherical lenslets to see if photolithography flat microstructure lenses works to prevent myopia in children.

Participants will:

Wear photolithography flat microstructure lenses or Spectacle Lenses with Aspherical Lenslets more than 8H per day for 1 year.

Visit the clinic once every 3 months for checkups and tests.

The 5 groups in the trial

  • PPML(multi-point defocus design, non-fading, Nuo Tong)Treatment being tested

    The group wears photolithography plano microstructure lenses (PPML) with a multi-point defocus design, manufactured by Nuo Tong, which feature a non-fading optical property.

    Treatment: wearing photolithography plano microstructure lenses with multi-point defocus design, non-fading optical property

  • PPML (multi-point defocus design, color, light transmittance 55% after photochromism, Nuo Tong)Treatment being tested

    PPML (Photolithography Plano Microstructure Lenses) incorporates a multi-point defocus optical architecture manufactured by Nuo Tong, featuring photochromic properties with a light transmittance of 55% post-activation.

    Treatment: wearing Photolithography Plano Microstructure Lenses incorporates a multi-point defocus optical architecture , featuring photochromic properties with a light transmittance of 55% post-activation

  • PPML (multi-point defocus design, color, light transmittance 35% after photochromism, Nuo Tong)Treatment being tested

    PPML (Photolithography Plano Microstructure Lenses) incorporates a multi-point defocus optical architecture manufactured by Nuo Tong, featuring photochromic properties with a light transmittance of 35% post-activation.

    Treatment: wearing Photolithography Plano Microstructure Lenses incorporates a multi-point defocus optical architecture , featuring photochromic properties with a light transmittance of 35% post-activation

  • PPML (designed to reduce contrast, non-fading, Nuo Tong)Treatment being tested

    PPML (Photolithography Plano Microstructure Lenses), designed by Nuo Tong to reduce contrast sensitivity and featuring a non-fading optical property

    Treatment: wearing Photolithography Plano Microstructure Lenses designed to reduce contrast sensitivity and featuring a non-fading optical property

  • Plano microstructure lenses (multi-point defocus design,Aspherical Lenslets, Essilor Stellest)Existing treatment, for comparison

    Plano microstructure lenses featuring multi-point defocus design with aspherical lenslets (Essilor Stellest)

    Treatment: wearing Plano microstructure lenses featuring multi-point defocus design with aspherical lenslets (Essilor Stellest)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparative Efficacy and Safety of Multi-Type Photolithography Flat Microstructure Spectacle Lenses Versus Spectacle Lenses With Aspherical Lenslets for Myopia Control in Chinese Children: A 12-Month Randomized Controlled Trial
Criteria questions
Built from NCT07535658, who can take part
Record updated
17 April 2026